Join
Share on Facebook Printer Friendly Page More Sharing Summarizing
ProPublica   

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

Shared By
Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In Alicia Jackson, director of the Advanced Research Projects Agency for Health, speaks at an event earlier this year. Photo illustration by ProPublica. Photo by Tom Williams/CQ-Roll Call, Inc via Getty Images. Last November, the Department of Health and Human Services announced the elimination of 'black box' warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a key treatment for menopause symptoms.
Read the rest of the story HERE:

At www.propublica.org from ProPublica

View All RSS Feeds

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines